Oak Thistle LLC Takes $2.21 Million Position in HCA Healthcare, Inc. $HCA

Oak Thistle LLC acquired a new stake in shares of HCA Healthcare, Inc. (NYSE:HCA) during the 4th quarter, according to its most recent 13F filing with the SEC. The firm acquired 4,736 shares of the company’s stock, valued at approximately $2,211,000.

Several other institutional investors and hedge funds have also recently modified their holdings of HCA. Pacer Advisors Inc. increased its holdings in HCA Healthcare by 6,115.3% in the 3rd quarter. Pacer Advisors Inc. now owns 911,096 shares of the company’s stock valued at $388,309,000 after acquiring an additional 896,437 shares during the last quarter. Viking Global Investors LP increased its holdings in HCA Healthcare by 58.5% in the 2nd quarter. Viking Global Investors LP now owns 1,872,133 shares of the company’s stock valued at $717,214,000 after acquiring an additional 690,773 shares during the last quarter. Danske Bank A S purchased a new position in shares of HCA Healthcare in the 3rd quarter worth $115,530,000. Zurich Insurance Group Ltd FI grew its stake in shares of HCA Healthcare by 3,755.9% in the 3rd quarter. Zurich Insurance Group Ltd FI now owns 269,912 shares of the company’s stock worth $115,036,000 after buying an additional 262,912 shares in the last quarter. Finally, Mondrian Investment Partners LTD purchased a new position in shares of HCA Healthcare in the 3rd quarter worth $106,605,000. 62.73% of the stock is currently owned by institutional investors.

HCA Healthcare Stock Performance

NYSE:HCA opened at $488.74 on Wednesday. HCA Healthcare, Inc. has a one year low of $314.43 and a one year high of $556.52. The firm has a market cap of $109.27 billion, a P/E ratio of 17.22, a P/E/G ratio of 1.45 and a beta of 1.36. The firm has a 50-day simple moving average of $511.03 and a 200-day simple moving average of $480.20.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings results on Tuesday, January 27th. The company reported $8.01 EPS for the quarter, beating the consensus estimate of $7.37 by $0.64. The business had revenue of $19.51 billion during the quarter, compared to analyst estimates of $19.67 billion. HCA Healthcare had a net margin of 8.97% and a negative return on equity of 409.11%. The company’s quarterly revenue was up 6.7% compared to the same quarter last year. During the same quarter in the previous year, the business posted $6.22 EPS. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, research analysts predict that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 31st. Investors of record on Tuesday, March 17th were paid a dividend of $0.78 per share. This is a boost from HCA Healthcare’s previous quarterly dividend of $0.72. The ex-dividend date was Tuesday, March 17th. This represents a $3.12 annualized dividend and a dividend yield of 0.6%. HCA Healthcare’s dividend payout ratio (DPR) is presently 10.99%.

Insider Activity

In related news, EVP Michael S. Cuffe sold 1,500 shares of the business’s stock in a transaction that occurred on Tuesday, February 3rd. The shares were sold at an average price of $498.09, for a total transaction of $747,135.00. Following the completion of the transaction, the executive vice president owned 30,003 shares in the company, valued at $14,944,194.27. The trade was a 4.76% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, SVP Christopher F. Wyatt sold 4,000 shares of the business’s stock in a transaction that occurred on Wednesday, February 11th. The stock was sold at an average price of $505.00, for a total transaction of $2,020,000.00. Following the transaction, the senior vice president owned 44,379 shares of the company’s stock, valued at approximately $22,411,395. This trade represents a 8.27% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders have sold 15,214 shares of company stock worth $7,797,595. Insiders own 1.50% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have commented on HCA shares. Deutsche Bank Aktiengesellschaft lifted their price objective on shares of HCA Healthcare from $500.00 to $558.00 and gave the stock a “buy” rating in a research note on Wednesday, January 28th. Sanford C. Bernstein set a $541.00 price target on shares of HCA Healthcare in a research note on Monday, February 9th. UBS Group lifted their price target on shares of HCA Healthcare from $598.00 to $635.00 and gave the stock a “buy” rating in a research note on Monday, February 23rd. Wall Street Zen cut shares of HCA Healthcare from a “strong-buy” rating to a “buy” rating in a research note on Saturday, February 14th. Finally, Leerink Partners lifted their price target on shares of HCA Healthcare from $507.00 to $573.00 and gave the stock an “outperform” rating in a research note on Wednesday, January 28th. Sixteen research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $537.73.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.